Chemours Co【CC】

Market cap

$2.1B

P/E ratio

	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Net sales	-	-	-	6,638	5,526	4,969	6,345	6,794	6,027	5,782
Cost of goods sold	-	-	-	4,667	4,463	3,902	4,964	5,178	4,721	4,631
Gross profit	955	1,110	1,754	1,971	1,063	1,067	1,381	1,616	1,306	1,151
Selling, General and Administrative Expense	632	934	602	657	548	527	592	710	1,290	585
Research and development expense	97	80	80	82	80	93	107	118	108	109
Restructuring, asset-related, and other charges	-	-	-	49	87	80	6	16	153	60
Goodwill, Impairment Loss	25	-	-	-	-	-	-	-	-	56
Total other operating expenses	1,087	1,184	739	788	715	700	705	844	1,551	810
Equity in earnings of affiliates	22	29	33	43	29	23	43	55	45	43
Interest expense, net	132	213	215	195	208	210	185	163	208	264
(Loss) gain on extinguishment of debt	-	-	-	-38	-	-22	-21	7	-1	-1
Other income, net	-	-	-	162	-293	21	163	70	91	8
Income (loss) before income taxes	-188	-11	912	1,155	-124	179	676	741	-318	127
Income Tax Expense (Benefit)	-98	-18	165	159	-72	-40	68	163	-81	41
Net income (loss)	-90	7	747	996	-52	219	608	578	-237	86
Net Income (Loss) Attributable to Noncontrolling Interest	-	-	1	1	-	-	-	-	-1	-
Net income (loss) attributable to Chemours	-90	7	747	996	-52	219	608	578	-237	86
Earnings Per Share, Basic	-0.5	0.04	4.04	5.62	-0.32	1.33	3.69	3.72	-1.6	0.58
Earnings Per Share, Diluted	-0.5	0.04	3.91	5.45	-0.32	1.32	3.6	3.65	-1.6	0.57